Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175


Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.

Kamath AT, Valenti MP, Rochat AF, Agger EM, Lingnau K, von Gabain A, Andersen P, Lambert PH, Siegrist CA.

Eur J Immunol. 2008 May;38(5):1247-56. doi: 10.1002/eji.200737889.


Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.

Kamath AT, Rochat AF, Valenti MP, Agger EM, Lingnau K, Andersen P, Lambert PH, Siegrist CA.

PLoS One. 2008;3(11):e3683. doi: 10.1371/journal.pone.0003683. Epub 2008 Nov 10.


A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells.

Kamath AT, Rochat AF, Christensen D, Agger EM, Andersen P, Lambert PH, Siegrist CA.

PLoS One. 2009 Jun 3;4(6):e5771. doi: 10.1371/journal.pone.0005771.


Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.

Engel AL, Sun GC, Gad E, Rastetter LR, Strobe K, Yang Y, Dang Y, Disis ML, Lu H.

Immunobiology. 2013 Dec;218(12):1468-76. doi: 10.1016/j.imbio.2013.05.001. Epub 2013 May 13.


Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL.

Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.


Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.

Kamath AT, Mastelic B, Christensen D, Rochat AF, Agger EM, Pinschewer DD, Andersen P, Lambert PH, Siegrist CA.

J Immunol. 2012 May 15;188(10):4828-37. doi: 10.4049/jimmunol.1103183. Epub 2012 Apr 13.


NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V.

J Immunol. 2003 Nov 15;171(10):5140-7.


Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.

Triccas JA, Shklovskaya E, Spratt J, Ryan AA, Palendira U, Fazekas de St Groth B, Britton WJ.

Infect Immun. 2007 Nov;75(11):5368-75. Epub 2007 Aug 27.


Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer.

Ko SY, Lee KA, Youn HJ, Kim YJ, Ko HJ, Heo TH, Kweon MN, Kang CY.

Eur J Immunol. 2007 Aug;37(8):2127-37.


Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.

BMC Immunol. 2009 Aug 3;10:43. doi: 10.1186/1471-2172-10-43.


TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.

Tyne AS, Chan JG, Shanahan ER, Atmosukarto I, Chan HK, Britton WJ, West NP.

Vaccine. 2013 Sep 13;31(40):4322-9. doi: 10.1016/j.vaccine.2013.07.022. Epub 2013 Jul 20.


Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells.

Dong H, Stanek O, Salvador FR, Länger U, Morillon E, Ung C, Sebo P, Leclerc C, Majlessi L.

Mucosal Immunol. 2013 May;6(3):522-34. doi: 10.1038/mi.2012.92. Epub 2012 Oct 3.


Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model.

Schreiber HA, Hulseberg PD, Lee J, Prechl J, Barta P, Szlavik N, Harding JS, Fabry Z, Sandor M.

PLoS One. 2010 Jul 6;5(7):e11453. doi: 10.1371/journal.pone.0011453.


ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.

Silva-Sánchez A, Meza-Pérez S, Flores-Langarica A, Donis-Maturano L, Estrada-García I, Calderón-Amador J, Hernández-Pando R, Idoyaga J, Steinman RM, Flores-Romo L.

PLoS One. 2015 Apr 27;10(4):e0124828. doi: 10.1371/journal.pone.0124828. eCollection 2015 Apr 27.


CD4(+) T-cell activation is differentially modulated by bacteria-primed dendritic cells, but is generally down-regulated by n-3 polyunsaturated fatty acids.

Brix S, Lund P, Kjaer TM, Straarup EM, Hellgren LI, Frøkiaer H.

Immunology. 2010 Mar;129(3):338-50. doi: 10.1111/j.1365-2567.2009.03163.x. Epub 2009 Nov 11.


Antigen depot is not required for alum adjuvanticity.

Hutchison S, Benson RA, Gibson VB, Pollock AH, Garside P, Brewer JM.

FASEB J. 2012 Mar;26(3):1272-9. doi: 10.1096/fj.11-184556. Epub 2011 Nov 21.


Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen.

Wikstrom ME, Batanero E, Smith M, Thomas JA, von Garnier C, Holt PG, Stumbles PA.

J Immunol. 2006 Jul 15;177(2):913-24.


Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.

Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.

Vaccine. 2009 Jan 1;27(1):28-37. doi: 10.1016/j.vaccine.2008.10.034. Epub 2008 Oct 31.


Supplemental Content

Support Center